A Glycosylated Covalent Organic Framework Equipped with BODIPY and CaCO3 for Synergistic Tumor Therapy

Ca2+, a ubiquitous but nuanced modulator of cellular physiology, is meticulously controlled intracellularly. However, intracellular Ca2+ regulation, such as mitochondrial Ca2+ buffering capacity, can be disrupted by 1O2. Thus, the intracellular Ca2+ overload, which is recognized as one of the import...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie International Edition Vol. 59; no. 41; pp. 18042 - 18047
Main Authors Guan, Qun, Zhou, Le‐Le, Lv, Fan‐Hong, Li, Wen‐Yan, Li, Yan‐An, Dong, Yu‐Bin
Format Journal Article
LanguageEnglish
Published Weinheim Wiley Subscription Services, Inc 05.10.2020
EditionInternational ed. in English
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Ca2+, a ubiquitous but nuanced modulator of cellular physiology, is meticulously controlled intracellularly. However, intracellular Ca2+ regulation, such as mitochondrial Ca2+ buffering capacity, can be disrupted by 1O2. Thus, the intracellular Ca2+ overload, which is recognized as one of the important cell pro‐death factors, can be logically achieved by the synergism of 1O2 with exogenous Ca2+ delivery. Reported herein is a nanoscale covalent organic framework (NCOF)‐based nanoagent, namely CaCO3@COF‐BODIPY‐2I@GAG (4), which is embedded with CaCO3 nanoparticle (NP) and surface‐decorated with BODIPY‐2I as photosensitizer (PS) and glycosaminoglycan (GAG) targeting agent for CD44 receptors on digestive tract tumor cells. Under illumination, the light‐triggered 1O2 not only kills the tumor cells directly, but also leads to their mitochondrial dysfunction and Ca2+ overload. An enhanced antitumor efficiency is achieved via photodynamic therapy (PDT) and Ca2+ overload synergistic therapy. A multifunctional COF‐based nanoagent, which is equipped with BODIPY‐2I photosensitizer, CaCO3 nanoparticle, and glycosaminoglycan (GAG) targeting agent, can be a highly efficient and selective antitumor nanomedicine for colon tumor via photodynamic therapy (PDT) and Ca2+ overload synergistic therapy.
AbstractList Ca2+ , a ubiquitous but nuanced modulator of cellular physiology, is meticulously controlled intracellularly. However, intracellular Ca2+ regulation, such as mitochondrial Ca2+ buffering capacity, can be disrupted by 1 O2 . Thus, the intracellular Ca2+ overload, which is recognized as one of the important cell pro-death factors, can be logically achieved by the synergism of 1 O2 with exogenous Ca2+ delivery. Reported herein is a nanoscale covalent organic framework (NCOF)-based nanoagent, namely CaCO3 @COF-BODIPY-2I@GAG (4), which is embedded with CaCO3 nanoparticle (NP) and surface-decorated with BODIPY-2I as photosensitizer (PS) and glycosaminoglycan (GAG) targeting agent for CD44 receptors on digestive tract tumor cells. Under illumination, the light-triggered 1 O2 not only kills the tumor cells directly, but also leads to their mitochondrial dysfunction and Ca2+ overload. An enhanced antitumor efficiency is achieved via photodynamic therapy (PDT) and Ca2+ overload synergistic therapy.Ca2+ , a ubiquitous but nuanced modulator of cellular physiology, is meticulously controlled intracellularly. However, intracellular Ca2+ regulation, such as mitochondrial Ca2+ buffering capacity, can be disrupted by 1 O2 . Thus, the intracellular Ca2+ overload, which is recognized as one of the important cell pro-death factors, can be logically achieved by the synergism of 1 O2 with exogenous Ca2+ delivery. Reported herein is a nanoscale covalent organic framework (NCOF)-based nanoagent, namely CaCO3 @COF-BODIPY-2I@GAG (4), which is embedded with CaCO3 nanoparticle (NP) and surface-decorated with BODIPY-2I as photosensitizer (PS) and glycosaminoglycan (GAG) targeting agent for CD44 receptors on digestive tract tumor cells. Under illumination, the light-triggered 1 O2 not only kills the tumor cells directly, but also leads to their mitochondrial dysfunction and Ca2+ overload. An enhanced antitumor efficiency is achieved via photodynamic therapy (PDT) and Ca2+ overload synergistic therapy.
Ca2+, a ubiquitous but nuanced modulator of cellular physiology, is meticulously controlled intracellularly. However, intracellular Ca2+ regulation, such as mitochondrial Ca2+ buffering capacity, can be disrupted by 1O2. Thus, the intracellular Ca2+ overload, which is recognized as one of the important cell pro‐death factors, can be logically achieved by the synergism of 1O2 with exogenous Ca2+ delivery. Reported herein is a nanoscale covalent organic framework (NCOF)‐based nanoagent, namely CaCO3@COF‐BODIPY‐2I@GAG (4), which is embedded with CaCO3 nanoparticle (NP) and surface‐decorated with BODIPY‐2I as photosensitizer (PS) and glycosaminoglycan (GAG) targeting agent for CD44 receptors on digestive tract tumor cells. Under illumination, the light‐triggered 1O2 not only kills the tumor cells directly, but also leads to their mitochondrial dysfunction and Ca2+ overload. An enhanced antitumor efficiency is achieved via photodynamic therapy (PDT) and Ca2+ overload synergistic therapy. A multifunctional COF‐based nanoagent, which is equipped with BODIPY‐2I photosensitizer, CaCO3 nanoparticle, and glycosaminoglycan (GAG) targeting agent, can be a highly efficient and selective antitumor nanomedicine for colon tumor via photodynamic therapy (PDT) and Ca2+ overload synergistic therapy.
Ca2+, a ubiquitous but nuanced modulator of cellular physiology, is meticulously controlled intracellularly. However, intracellular Ca2+ regulation, such as mitochondrial Ca2+ buffering capacity, can be disrupted by 1O2. Thus, the intracellular Ca2+ overload, which is recognized as one of the important cell pro‐death factors, can be logically achieved by the synergism of 1O2 with exogenous Ca2+ delivery. Reported herein is a nanoscale covalent organic framework (NCOF)‐based nanoagent, namely CaCO3@COF‐BODIPY‐2I@GAG (4), which is embedded with CaCO3 nanoparticle (NP) and surface‐decorated with BODIPY‐2I as photosensitizer (PS) and glycosaminoglycan (GAG) targeting agent for CD44 receptors on digestive tract tumor cells. Under illumination, the light‐triggered 1O2 not only kills the tumor cells directly, but also leads to their mitochondrial dysfunction and Ca2+ overload. An enhanced antitumor efficiency is achieved via photodynamic therapy (PDT) and Ca2+ overload synergistic therapy.
Author Li, Wen‐Yan
Li, Yan‐An
Guan, Qun
Dong, Yu‐Bin
Zhou, Le‐Le
Lv, Fan‐Hong
Author_xml – sequence: 1
  givenname: Qun
  surname: Guan
  fullname: Guan, Qun
  organization: Shandong Normal University
– sequence: 2
  givenname: Le‐Le
  surname: Zhou
  fullname: Zhou, Le‐Le
  organization: Shandong Normal University
– sequence: 3
  givenname: Fan‐Hong
  surname: Lv
  fullname: Lv, Fan‐Hong
  organization: Shandong Normal University
– sequence: 4
  givenname: Wen‐Yan
  surname: Li
  fullname: Li, Wen‐Yan
  organization: Shandong Normal University
– sequence: 5
  givenname: Yan‐An
  surname: Li
  fullname: Li, Yan‐An
  email: yananli@sdnu.edu.cn
  organization: Shandong Normal University
– sequence: 6
  givenname: Yu‐Bin
  orcidid: 0000-0002-9698-8863
  surname: Dong
  fullname: Dong, Yu‐Bin
  email: yubindong@sdnu.edu.cn
  organization: Shandong Normal University
BookMark eNpdkM9PwjAUxxuDiYBePTfx4mXYH9vaHREBSYgzEQ-elq7rYLh1o90k--8twXDw9L7v5fN9-eY7AgNdawXAPUYTjBB5ErpQE4IIQhwFwRUY4oBgjzJGB077lHqMB_gGjKzdO55zFA5BPoXLspe17UvRqgzO6h9RKt3C2GzdQwkXRlTqWJtvOD90RdM45li0O_gcv6zev6DQziNmMYV5beBHr5XZFrZ1xk1Xuctmp4xo-ltwnYvSqru_OQafi_lm9uqt4-VqNl17W4J54GGMMj8McSQZkRFNUSRYmFKfCEZCmoVE5inmlBMuJWNK4SyPuHIq4CjlMqdj8Hj-25j60CnbJlVhpSpLoVXd2YT4mGPCSYAd-vAP3ded0S6do_yQuTwBc1R0po5FqfqkMUUlTJ9glJw6T06dJ5fOk-nban7Z6C_LvHfw
ContentType Journal Article
Copyright 2020 Wiley‐VCH GmbH
2020 Wiley-VCH GmbH.
Copyright_xml – notice: 2020 Wiley‐VCH GmbH
– notice: 2020 Wiley-VCH GmbH.
DBID 7TM
K9.
7X8
DOI 10.1002/anie.202008055
DatabaseName Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle ProQuest Health & Medical Complete (Alumni)
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

ProQuest Health & Medical Complete (Alumni)
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1521-3773
Edition International ed. in English
EndPage 18047
ExternalDocumentID ANIE202008055
Genre article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  funderid: 21805172; 21971153, 21671122
GroupedDBID ---
-DZ
-~X
.3N
.GA
05W
0R~
10A
1L6
1OB
1OC
1ZS
23M
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
6TJ
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABPPZ
ABPVW
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACIWK
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BTSUX
BY8
CS3
D-E
D-F
D0L
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
EBS
F00
F01
F04
F5P
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LYRES
M53
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RNS
ROL
RWI
RX1
RYL
SUPJJ
TN5
UB1
UPT
UQL
V2E
VQA
W8V
W99
WBFHL
WBKPD
WH7
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XPP
XSW
XV2
YZZ
ZZTAW
~IA
~KM
~WT
7TM
ABDBF
ABJNI
AEYWJ
AGHNM
AGYGG
K9.
7X8
ID FETCH-LOGICAL-g2185-110d46619c72c93b09a76b342a7263d62cfb183828cc77ee1df98e77e580b8cf3
IEDL.DBID DR2
ISSN 1433-7851
1521-3773
IngestDate Fri Jul 11 04:27:22 EDT 2025
Fri Jul 25 12:02:27 EDT 2025
Wed Jan 22 16:33:45 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 41
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-g2185-110d46619c72c93b09a76b342a7263d62cfb183828cc77ee1df98e77e580b8cf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9698-8863
PQID 2446718557
PQPubID 946352
PageCount 6
ParticipantIDs proquest_miscellaneous_2418128251
proquest_journals_2446718557
wiley_primary_10_1002_anie_202008055_ANIE202008055
PublicationCentury 2000
PublicationDate October 5, 2020
PublicationDateYYYYMMDD 2020-10-05
PublicationDate_xml – month: 10
  year: 2020
  text: October 5, 2020
  day: 05
PublicationDecade 2020
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
PublicationTitle Angewandte Chemie International Edition
PublicationYear 2020
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2017; 5
2018; 1870
2017; 3
2019; 11
2019; 55
2019; 13
2019; 14
2020 2020; 59 132
2009; 275
2020; 12
2020; 11
2019; 286
2020; 8
2014; 369
2018; 293
2013; 12
2019; 24
2016; 41
2015 2015; 54 127
2018; 30
2018; 33
2019; 8
2019; 9
2019; 6
2019; 5
2019; 2
2019; 309
2011; 30
2019; 149
2020; 106
2020; 107
2017; 29
2006; 1
2015; 8
2015; 7
2019 2019; 58 131
2016; 56
2020
2017; 13
2020 2020
2020; 27
2020; 26
2016
2009; 6
2020; 21
2018; 12
2018; 11
2008; 40
2018; 54
2016; 8
2018; 13
References_xml – volume: 309
  start-page: 82
  year: 2019
  end-page: 93
  publication-title: J. Controlled Release
– volume: 8
  year: 2015
  publication-title: Sci. Signaling
– volume: 11
  start-page: 27512
  year: 2019
  end-page: 27520
  publication-title: ACS Appl. Mater. Interfaces
– volume: 59 132
  start-page: 5050 5086
  year: 2020 2020
  end-page: 5091 5129
  publication-title: Angew. Chem. Int. Ed. Angew. Chem.
– volume: 55
  start-page: 14898
  year: 2019
  end-page: 14901
  publication-title: Chem. Commun.
– volume: 6
  start-page: 1062
  year: 2009
  end-page: 1073
  publication-title: Mol. Pharm.
– volume: 13
  start-page: 13985
  year: 2019
  end-page: 13994
  publication-title: ACS Nano
– volume: 11
  start-page: 3385
  year: 2018
  end-page: 3395
  publication-title: Nano Res.
– volume: 5
  start-page: 2068
  year: 2017
  end-page: 2073
  publication-title: J. Mater. Chem. B
– volume: 40
  start-page: 1356
  year: 2008
  end-page: 1361
  publication-title: Surf. Interface Anal.
– volume: 12
  start-page: 703
  year: 2013
  end-page: 719
  publication-title: Nat. Rev. Drug Discovery
– volume: 11
  year: 2019
  publication-title: Cold Spring Harbor Perspect. Biol.
– volume: 12
  start-page: 2094
  year: 2018
  end-page: 2105
  publication-title: ACS Nano
– volume: 3
  start-page: 17045
  year: 2017
  publication-title: Cell Death Discovery
– volume: 21
  start-page: 85
  year: 2020
  end-page: 100
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 8
  year: 2019
  publication-title: Adv. Healthcare Mater.
– volume: 6
  year: 2019
  publication-title: Adv. Sci.
– volume: 7
  start-page: 905
  year: 2015
  end-page: 912
  publication-title: Nat. Chem.
– volume: 9
  start-page: 6867
  year: 2019
  end-page: 6884
  publication-title: Theranostics
– volume: 293
  start-page: 17081
  year: 2018
  end-page: 17094
  publication-title: J. Biol. Chem.
– volume: 8
  start-page: 31510
  year: 2016
  end-page: 31523
  publication-title: ACS Appl. Mater. Interfaces
– volume: 13
  start-page: 3884
  year: 2019
  end-page: 3895
  publication-title: ACS Nano
– volume: 1870
  start-page: 123
  year: 2018
  end-page: 136
  publication-title: Biochim. Biophys. Acta Rev. Cancer
– volume: 14
  start-page: 180
  year: 2019
  end-page: 198
  publication-title: iScience
– volume: 275
  start-page: 9
  year: 2009
  end-page: 16
  publication-title: Cancer Lett.
– volume: 24
  start-page: 758
  year: 2019
  end-page: 772
  publication-title: Apoptosis
– volume: 8
  start-page: 20614
  year: 2016
  end-page: 20624
  publication-title: ACS Appl. Mater. Interfaces
– volume: 54
  start-page: 11268
  year: 2018
  end-page: 11271
  publication-title: Chem. Commun.
– year: 2020 2020
  publication-title: Angew. Chem. Int. Ed. Angew. Chem.
– start-page: 448
  year: 2016
  end-page: 467
– volume: 54 127
  start-page: 919 933
  year: 2015 2015
  end-page: 922 936
  publication-title: Angew. Chem. Int. Ed. Angew. Chem.
– year: 2020
  publication-title: Adv. Funct. Mater.
– volume: 1
  start-page: 2315
  year: 2006
  end-page: 2319
  publication-title: Nat. Protoc.
– volume: 369
  year: 2014
  publication-title: Philos. Trans. R. Soc. London Ser. B
– volume: 8
  start-page: 2931
  year: 2020
  end-page: 2938
  publication-title: Biomater. Sci.
– volume: 27
  start-page: 128
  year: 2020
  end-page: 136
  publication-title: Drug Delivery
– volume: 107
  year: 2020
  publication-title: Prog. Mater. Sci.
– volume: 286
  start-page: 241
  year: 2019
  end-page: 278
  publication-title: FEBS J.
– volume: 2
  start-page: 1194
  year: 2019
  end-page: 1201
  publication-title: ACS Appl. Nano Mater.
– volume: 11
  start-page: 74
  year: 2019
  publication-title: Nano-Micro Lett.
– volume: 30
  start-page: 4119
  year: 2011
  end-page: 4125
  publication-title: EMBO J.
– volume: 149
  start-page: 86
  year: 2019
  end-page: 92
  publication-title: Carbon
– volume: 26
  start-page: 5583
  year: 2020
  end-page: 5591
  publication-title: Chem. Eur. J.
– volume: 14
  start-page: 27
  year: 2019
  end-page: 35
  publication-title: iScience
– volume: 56
  start-page: 85
  year: 2016
  end-page: 102
  publication-title: Annu. Rev. Pharmacol. Toxicol.
– volume: 12
  start-page: 16058
  year: 2020
  end-page: 16075
  publication-title: ACS Appl. Mater. Interfaces
– volume: 5
  start-page: 2171
  year: 2019
  end-page: 2182
  publication-title: Chem
– volume: 8
  start-page: 2792
  year: 2020
  end-page: 2804
  publication-title: J. Mater. Chem. B
– volume: 30
  year: 2018
  publication-title: Adv. Mater.
– volume: 29
  start-page: 8042
  year: 2017
  end-page: 8046
  publication-title: Chem. Mater.
– volume: 58 131
  start-page: 14066 14204
  year: 2019 2019
  end-page: 14080 14219
  publication-title: Angew. Chem. Int. Ed. Angew. Chem.
– volume: 11
  start-page: 1735
  year: 2020
  publication-title: Nat. Commun.
– volume: 13
  start-page: 13304
  year: 2019
  end-page: 13316
  publication-title: ACS Nano
– volume: 106
  year: 2020
  publication-title: Mater. Sci. Eng. C
– volume: 33
  start-page: 985
  year: 2018
  end-page: 1003
  publication-title: Cancer Cell
– volume: 41
  start-page: 1035
  year: 2016
  end-page: 1049
  publication-title: Trends Biochem. Sci.
– volume: 11
  start-page: 18995
  year: 2019
  end-page: 19005
  publication-title: ACS Appl. Mater. Interfaces
– volume: 13
  year: 2017
  publication-title: Small
– volume: 5
  start-page: 153
  year: 2019
  end-page: 166
  publication-title: ACS Cent. Sci.
– volume: 13
  start-page: 3122
  year: 2018
  end-page: 3149
  publication-title: Chem. Asian J.
SSID ssj0028806
Score 2.6074374
Snippet Ca2+, a ubiquitous but nuanced modulator of cellular physiology, is meticulously controlled intracellularly. However, intracellular Ca2+ regulation, such as...
Ca2+ , a ubiquitous but nuanced modulator of cellular physiology, is meticulously controlled intracellularly. However, intracellular Ca2+ regulation, such as...
SourceID proquest
wiley
SourceType Aggregation Database
Publisher
StartPage 18042
SubjectTerms Calcium (intracellular)
Calcium (mitochondrial)
Calcium buffering
Calcium carbonate
Calcium ions
calcium overload
cancer
Cancer therapies
CD44 antigen
Cell death
covalent organic frameworks
Gastrointestinal tract
Glycosaminoglycans
Intracellular
Mitochondria
Nanoparticles
Overloading
Photodynamic therapy
reticular chemistry
Synergism
Tumor cells
Title A Glycosylated Covalent Organic Framework Equipped with BODIPY and CaCO3 for Synergistic Tumor Therapy
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fanie.202008055
https://www.proquest.com/docview/2446718557
https://www.proquest.com/docview/2418128251
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NT4MwFG-MF734bZxOUxOvKLSUwnHi5jRxGp2JnkhbwBgnTDcO86_3PRj4cdRb-SiBx2v7a9_7_UrIkafdwNGOslJpHAwzCksnMHFltla-CST3XeQ7Xw28_r17-SAevrH4K32IZsENW0bZX2MDV3py8iUaigxsmN9h_N4WyDLHhC1ERbeNfhQD56zoRZxbuAt9rdpos5Of1X_gy-8otRxmeqtE1S9YZZe8HBdTfWw-fmk3_ucL1sjKHIPSTuU062QhyTbIUlhv_bZJ0g49H81MPpmNAIrGNMzBH2F0ohVz09BendJFu2_F83gM9-CCLj29Pru4eaQqgzoqvOYUIDG9myG_sBSEpsPiFc4MKymDLXLf6w7DvjXfkMF6AiQgLIAKsQsDemAkMwHXdqCkp7nLlGQejz1mUg1dBEzijJEySZw4DfwESsK3tW9Svk0WszxLdgj14DnaVspw6BCUL6CAEb5U-FLHqS1apF3_kGjeqiYRQBEPxlIhZIscNpfBNhjkUFmSF3gPYhYk5LYIK60fjSvdjqhSaGYR2j1q7B51Bhfd5mj3L5X2yDKWyxw_0SaL0_ci2QesMtUHpT9-AkFR4Aw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lc9MwEN6h4ZBe2vKahqYgZrg6cSTLso9pSEggDwaSGTh5JNlmmAYnkPiQ_np27dhQjnCTZcljryXtt1rttwCvfeOFPdPTTqpsj9yM0jEJGq7cNTqwoRKBR_HOs7k_XnnvPsvqNCHFwpT8EPWGG82MYr2mCU4b0t3frKEUgo0GHjnwXSlP4CGl9S6sqo81gxTH4VkGGAnhUB76irfR5d37_e8hzD9xaqFoRudgqlcsz5fcdvK96di7v9gb_-sbLuDsCENZvxw3j-BBkj2G5qDK_vYE0j57uz7Yze6wRjQas8EGhyQqKFYGb1o2qk51seGP_Nt2i21oT5fdLN5MPnxhOsM-erAQDFEx-3SgEMOCE5ot8-9YsyzZDJ7CajRcDsbOMSeD8xXBgHQQLcQe6vTQKm5DYdxQK98Ij2vFfRH73KYGVwm046xVKkl6cRoGCZZk4JrApuIZNLJNllwC8_E5xtXaClwTdCCxQE6-VAbKxKkrW9Cu_kh0nFi7CNGIj-pUStWCV_VtlA35OXSWbHJqQ7CFYnJbwAvxR9uSuiMqSZp5RHKParlH_flkWF89_5dOL6E5Xs6m0XQyf38Fp1RfHPmTbWjsf-bJNUKXvXlRDM5fVv7kJw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED8xkLa98LENrVCYkXgNpHYcJ4-lH9ABBW1FYk-R7SQIjaWFNg_lr-cuaQLsEd4cx46Sy9n3O5_vZ4B933hhy7S0kyrbojCjdEyCjit3jQ5sqETgUb7z-dA_ufJ-XsvrF1n8JT9EveBGI6OYr2mAT-L08Jk0lDKw0b-j-L0r5QdY8Xw3IL3u_qoJpDhqZ5lfJIRDx9BXtI0uP3zd_xXAfAlTCzvTXwNdvWG5veTvQT4zB_bxP_LG93zCOqwuQChrl1qzAUtJ9gU-daqz375C2mbHd3M7ns7vEIvGrDNGhUTzxMrUTcv61Z4u1rvPbycTbEMruuzooju4_MN0hn1050IwxMTs95wSDAtGaDbK_2HNqOQy-AZX_d6oc-IsTmRwbhAKSAexQuyhRQ-t4jYUxg218o3wuFbcF7HPbWpwjkAvzlqlkqQVp2GQYEkGrglsKjZhORtnyXdgPj7HuFpbgTOCDiQWKMSXykCZOHVlA5rVD4kWw2oaIRbx0ZhKqRqwV99G2VCUQ2fJOKc2BFooI7cBvJB-NCmJO6KSoplHJPeolnvUHg569dXWWzr9gI-X3X50NhiebsNnqi72-8kmLM8e8mQHccvM7Baq-QTR0eLf
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Glycosylated+Covalent+Organic+Framework+Equipped+with+BODIPY+and+CaCO3+for+Synergistic+Tumor+Therapy&rft.jtitle=Angewandte+Chemie+International+Edition&rft.au=Guan%2C+Qun&rft.au=Zhou%2C+Le%E2%80%90Le&rft.au=Lv%2C+Fan%E2%80%90Hong&rft.au=Li%2C+Wen%E2%80%90Yan&rft.date=2020-10-05&rft.issn=1433-7851&rft.eissn=1521-3773&rft.volume=59&rft.issue=41&rft.spage=18042&rft.epage=18047&rft_id=info:doi/10.1002%2Fanie.202008055&rft.externalDBID=10.1002%252Fanie.202008055&rft.externalDocID=ANIE202008055
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1433-7851&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1433-7851&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1433-7851&client=summon